{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:23Z","timestamp":1792839743574,"version":"4.5.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2014\/15\/B\/NZ6\/02378"],"award-info":[{"award-number":["2014\/15\/B\/NZ6\/02378"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The aim of the study was to determine how depression and cognitive dysfunction in patients with chronic hepatitis C virus (HCV) infection are affected by treatment with direct-acting antivirals (DAA). Fifty-two chronic hepatitis C patients underwent neurocognitive and psychological evaluation before therapy and 5\u20136 months later. Depression was measured by Beck Depression Inventory (BDI), anxiety by State-Trait Anxiety inventory (STAI), neuroticism by Eysenck Personality Inventory (N\/EPO-R), while Ruff Figural Fluency Test (RFFT), Wisconsin Card Sorting Test (WCST), The Grooved Pegboard Test (GPT), and California Verbal Learning Test (CVLT) were used to assess neurocognitive function. There was significant positive change in BDI scores (8.8\u2009\u00b1\u20096.6 vs 6.1\u2009\u00b1\u20096.1; p\u2009&lt;\u20090.0001) while the most striking improvement in cognitive tests was observed for CVLT sum of immediate recall from Trial-1 to Trial-5 (50.9\u2009\u00b1\u200910.0 to 54.1\u2009\u00b1\u200910.0; p\u2009=\u20090.0005) and RFFT, where the number of unique designs increased from 77.2\u2009\u00b1\u200921.0 to 86.1\u2009\u00b1\u200928.3 (p\u2009&lt;\u20090.0001). These differences remained significant when patients with advanced (METAVIR grade F3\/F4) and those with mild (grade F0\/F1\/F2) liver disease were analyzed separately, although in general the improvements were more pronounced in the former group. In conclusion, in chronic HCV infection the brain function is markedly improved by DAA treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0320221","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:30:07Z","timestamp":1743787807000},"page":"e0320221","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Direct-acting antivirals (DAA) positively affect depression and cognitive function in patients with chronic hepatitis C"],"prefix":"10.1371","volume":"20","author":[{"given":"Tomasz","family":"Paw\u0142owski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Radkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3782-6442","authenticated-orcid":true,"given":"Karol","family":"Perlejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogna","family":"Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Berak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Horban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Laskus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"pone.0320221.ref001"},{"issue":"5","key":"pone.0320221.ref002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study","volume":"7","author":"Polaris Observatory HCVC","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5 Suppl 1","key":"pone.0320221.ref003","first-page":"S219","article-title":"Course and outcome of hepatitis C","volume":"36","author":"JH Hoofnagle","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"pone.0320221.ref004","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"P Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis"},{"issue":"5","key":"pone.0320221.ref005","first-page":"1355","article-title":"Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients","volume":"94","author":"A Barkhuizen","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"pone.0320221.ref006","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2002.30688","article-title":"Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease","volume":"35","author":"DM Forton","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"pone.0320221.ref007","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/jhep.2002.31257","article-title":"Neuropsychological impairment in patients with chronic hepatitis C","volume":"35","author":"RC Hilsabeck","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"pone.0320221.ref008","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/hep.20635","article-title":"Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors","volume":"41","author":"MP McAndrews","year":"2005","journal-title":"Hepatology"},{"issue":"9275","key":"pone.0320221.ref009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(00)05270-3","article-title":"Evidence for a cerebral effect of the hepatitis C virus","volume":"358","author":"DM Forton","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"pone.0320221.ref010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7861\/clinmedicine.1-1-54","article-title":"Applications of magnetic resonance spectroscopy to chronic liver disease","volume":"1","author":"SD Taylor-Robinson","year":"2001","journal-title":"Clin Med (Lond)"},{"issue":"5","key":"pone.0320221.ref011","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2004.07.022","article-title":"Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy","volume":"41","author":"K Weissenborn","year":"2004","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0320221.ref012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1020609213664","article-title":"1H MR spectroscopy of the brain in HIV-1-seropositive subjects: Evidence for diffuse metabolic abnormalities","volume":"13","author":"CD Marcus","year":"1998","journal-title":"Metab Brain Dis"},{"issue":"5","key":"pone.0320221.ref013","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.52.5.995","article-title":"Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients","volume":"52","author":"DJ Meyerhoff","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"pone.0320221.ref014","first-page":"83","article-title":"NeuroAIDS: A watershed for mental health and nervous system disorders","volume":"34","author":"JA McCombe","year":"2009","journal-title":"J Psychiatry Neurosci"},{"issue":"2","key":"pone.0320221.ref015","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/JVI.76.2.600-608.2002","article-title":"Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication","volume":"76","author":"M Radkowski","year":"2002","journal-title":"J Virol"},{"issue":"3","key":"pone.0320221.ref016","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/JVI.01890-08","article-title":"Hepatitis C virus neuroinvasion: Identification of infected cells","volume":"83","author":"J Wilkinson","year":"2009","journal-title":"J Virol"},{"issue":"3","key":"pone.0320221.ref017","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/519285","article-title":"Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV","volume":"196","author":"S Letendre","year":"2007","journal-title":"J Infect Dis"},{"issue":"10","key":"pone.0320221.ref018","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1128\/JVI.78.10.5170-5183.2004","article-title":"Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants","volume":"78","author":"DM Forton","year":"2004","journal-title":"J Virol"},{"issue":"19","key":"pone.0320221.ref019","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1128\/JVI.76.19.10064-10068.2002","article-title":"Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid","volume":"76","author":"T Laskus","year":"2002","journal-title":"J Virol"},{"issue":"10","key":"pone.0320221.ref020","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2009.199356","article-title":"Activation of brain macrophages\/microglia cells in hepatitis C infection","volume":"59","author":"J Wilkinson","year":"2010","journal-title":"Gut"},{"issue":"6","key":"pone.0320221.ref021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2893.2005.00706.x","article-title":"Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients","volume":"13","author":"A Cozzi","year":"2006","journal-title":"J Viral Hepat"},{"issue":"11","key":"pone.0320221.ref022","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/gut.2005.080267","article-title":"Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment","volume":"55","author":"K Weissenborn","year":"2006","journal-title":"Gut"},{"issue":"3","key":"pone.0320221.ref023","doi-asserted-by":"crossref","first-page":"453","DOI":"10.12740\/PP\/OnlineFirst\/105415","article-title":"Cognitive dysfunctions in depression - significance, description and treatment prospects","volume":"54","author":"A Czerwi\u0144ska","year":"2020","journal-title":"Psychiatr Pol"},{"key":"pone.0320221.ref024","doi-asserted-by":"crossref","first-page":"691067","DOI":"10.3389\/fncel.2021.691067","article-title":"Neuroinflammatory basis of depression: Learning from experimental models","volume":"15","author":"R Afridi","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"pone.0320221.ref025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12879-015-1305-1","article-title":"The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome","volume":"15","author":"J Jab\u0142o\u0144ska","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"8","key":"pone.0320221.ref026","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-1293.2007.00505.x","article-title":"Improved cognitive function as a consequence of hepatitis C virus treatment","volume":"8","author":"HH Thein","year":"2007","journal-title":"HIV Med"},{"issue":"3","key":"pone.0320221.ref027","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2011.09.015","article-title":"Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition","volume":"56","author":"V Byrnes","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0320221.ref028","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/ene.15138","article-title":"Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study","volume":"29","author":"L Ib\u00e1\u00f1ez-Samaniego","year":"2022","journal-title":"Eur J Neurol"},{"issue":"2","key":"pone.0320221.ref029","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PSY.0000000000001274","article-title":"The Severity of depressive symptoms as an independent predictor of sustained virological response during treatment of hepatitis C with pegylated interferon-\u03b12a and oral ribavirin","volume":"86","author":"T Paw\u0142owski","year":"2024","journal-title":"Psychosom Med"},{"issue":"9","key":"pone.0320221.ref030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: A systematic review","volume":"166","author":"O Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0320221.ref031","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study","volume":"55","author":"J Foucher","year":"2006","journal-title":"Gut"},{"key":"pone.0320221.ref032","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"AT Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"pone.0320221.ref033","doi-asserted-by":"crossref","unstructured":"Eysenck HJ, Eysenck SBG. Manual of the eysenck personality inventory. 1964.","DOI":"10.1037\/t02711-000"},{"issue":"3 & 4","key":"pone.0320221.ref034","article-title":"The state-trait anxiety inventory","volume":"5","author":"CD Spielberger","year":"2017","journal-title":"Rev Interam Psicol \/ Interam J Psychol"},{"key":"pone.0320221.ref035","unstructured":"Ruff RM. Ruff figural fluency test. n.d."},{"issue":"4","key":"pone.0320221.ref036","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1037\/h0059831","article-title":"A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem","volume":"38","author":"DA Grant","year":"1948","journal-title":"J Exp Psychol"},{"key":"pone.0320221.ref037","unstructured":"Delis D, Kramer J, Kaplan E, Ober B. California verbal learning test--second edition (CVLT\u2013II). 2000."},{"key":"pone.0320221.ref038","unstructured":"Matthews CG, Klove K. Instruction manual for the adult neuropsychology test battery. 1964."},{"issue":"1","key":"pone.0320221.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/neu.2016.69","article-title":"Inflammation and depression: A causal or coincidental link to the pathophysiology?","volume":"30","author":"BE Leonard","year":"2018","journal-title":"Acta Neuropsychiatr"},{"issue":"13","key":"pone.0320221.ref040","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/npp.2010.116","article-title":"Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters","volume":"35","author":"CB Zhu","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"pone.0320221.ref041","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"N M\u00fcller","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"5","key":"pone.0320221.ref042","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41386-020-00948-6","article-title":"Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: Results from a double-blind randomised clinical trial","volume":"46","author":"MA Nettis","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"pone.0320221.ref043","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.pnpbp.2010.07.015","article-title":"Inhibitory effects of SSRIs on IFN-\u03b3 induced microglial activation through the regulation of intracellular calcium","volume":"34","author":"H Horikawa","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"pone.0320221.ref044","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jare.2016.09.005","article-title":"Hepatitis C virus infection, and neurological and psychiatric disorders - A review","volume":"8","author":"L Yarlott","year":"2017","journal-title":"J Adv Res"},{"issue":"6","key":"pone.0320221.ref045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1017\/S1355617703960048","article-title":"Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C","volume":"9","author":"RC Hilsabeck","year":"2003","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"pone.0320221.ref046","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1038\/s41598-022-14736-3","article-title":"Different profiles of neurocognitive impairment in patients with hepatitis B and C virus infections","volume":"12","author":"CH Tan","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0320221.ref047","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/kjm2.12872","article-title":"Viral hepatitis moderates the impact of TGFB1 on neurocognitive impairment","volume":"40","author":"WC Tsao","year":"2024","journal-title":"Kaohsiung J Med Sci"},{"issue":"2","key":"pone.0320221.ref048","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcv.2014.03.004","article-title":"Depression and neuroticism in patients with chronic hepatitis C: Correlation with peripheral blood mononuclear cells activation","volume":"60","author":"T Pawlowski","year":"2014","journal-title":"J Clin Virol"},{"issue":"4","key":"pone.0320221.ref049","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","article-title":"Activation of central nervous system inflammatory pathways by interferon-alpha: Relationship to monoamines and depression","volume":"65","author":"CL Raison","year":"2009","journal-title":"Biol Psychiatry"},{"key":"pone.0320221.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.06.004","article-title":"Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-\u03b1 2a treatment","volume":"97","author":"T Pawlowski","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"pone.0320221.ref051","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1503\/jpn.190139","article-title":"The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-\u03b12a and oral ribavirin","volume":"46","author":"T Pawlowski","year":"2021","journal-title":"J Psychiatry Neurosci"},{"issue":"6","key":"pone.0320221.ref052","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/cells12060970","article-title":"HTR1A, TPH2, and 5-HTTLPR Polymorphisms and their impact on the severity of depressive symptoms and on the concentration of tryptophan catabolites during hepatitis C treatment with pegylated interferon-\u03b12a and oral ribavirin (PEG-IFN-\u03b12a\/RBV)","volume":"12","author":"T Pawlowski","year":"2023","journal-title":"Cells"},{"issue":"6","key":"pone.0320221.ref053","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/jvh.13492","article-title":"Hepatitis C related cognitive impairment: Impact of viral and host factors and response to therapy","volume":"28","author":"N Bar","year":"2021","journal-title":"J Viral Hepat"},{"issue":"5","key":"pone.0320221.ref054","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jvh.13668","article-title":"Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study","volume":"29","author":"H Kaur","year":"2022","journal-title":"J Viral Hepat"},{"issue":"6","key":"pone.0320221.ref055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jvh.13069","article-title":"Interferon-free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C","volume":"26","author":"J Bladowska","year":"2019","journal-title":"J Viral Hepat"},{"key":"pone.0320221.ref056","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2019.02.002","article-title":"Evaluation of brain volume alterations in HCV-infected patients after interferon-free therapy: A pilot study","volume":"399","author":"E Marciniewicz","year":"2019","journal-title":"J Neurol Sci"},{"issue":"5","key":"pone.0320221.ref057","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MEG.0000000000001790","article-title":"Can successful treatment by direct-acting antivirals improve depression in chronic HCV patients?","volume":"33","author":"ATA Moez","year":"2021","journal-title":"Eur J Gastroen Hepat"},{"issue":"1","key":"pone.0320221.ref058","article-title":"Effect of gender difference on psychiatric outcomes for hepatitis C virus patients receiving direct-acting antivirals in Egyptian population: A cohort study","volume":"58","author":"ZG Mahran","year":"2022","journal-title":"Egypt J Neurol Psych"},{"issue":"1","key":"pone.0320221.ref059","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/1516-4446-2018-0336","article-title":"Incidence of depression in patients with hepatitis C treated with direct-acting antivirals","volume":"42","author":"E Egmond","year":"2020","journal-title":"Braz J Psychiatry"},{"key":"pone.0320221.ref060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2020.12.128","article-title":"Depression in patients with chronic hepatitis-C treated with direct-acting antivirals: A real-world prospective observational study","volume":"282","author":"MA Khalil","year":"2021","journal-title":"J Affect Disord"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:31:23Z","timestamp":1743787883000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320221"}},"subtitle":[],"editor":[{"given":"Wan-Long","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320221","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}